The world’s polar bear population is projected to decline by two-thirds by 2050. A new study from the University of East Anglia suggests that polar bears are undergoing rapid genetic changes, and ...

The polar vortex is weakening, which means New England is in for a colder than usual December, with episodic cold snaps. Every year around this time, that phrase — “polar vortex” — starts to buzz ...

An extreme warming event high in the atmosphere is threatening to disrupt the polar vortex. We break down what that could mean for Canadians A rare, early, stratospheric warming event could shake up ...

High above the North Pole, in a slice of atmosphere rarely noticed and even less understood, a transformation is underway. Over the next 10 days, changes in the stratosphere will upend weather ...

Nearly all of New England has seen its share of frigid cold days and record mountain snow so far this November — and looking ahead, we’re about to get hit with another blast of Arctic air from a ...

Something unusual may be brewing in the stratosphere, and meteorologists say it could change the course of the winter forecast. The atmosphere is at a "critical juncture," and what happens in November ...

All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 7 minutes ...

In an early sign of the winter weather that's coming, the dreaded polar vortex is making news yet again. The polar vortex is "ramping up from its summer slumber," said meteorologist Judah Cohen in an ...

He remembers walking towards the worst experience of his life. The dorm hall was a concrete tunnel, with chipped white paint on the walls and a stench of sweat trapped inside. The stairs, he recalls, ...

Abstract: In view of the characteristics of processing face milling in turning center, this paper presents the polar coordinate interpolation algorithm based on particle movement. When processing face ...

Cartesian Therapeutics updates on Descartes-08 trials in myasthenia gravis and lupus, with financial results highlighting $182.1 million in cash. Cartesian Therapeutics, Inc. has announced the ...